Reuters logo
BRIEF-Iovance Biotherapeutics appoints Timothy Morris as chief financial officer
2017年8月8日 / 晚上8点27分 / 1 个月前

BRIEF-Iovance Biotherapeutics appoints Timothy Morris as chief financial officer

Aug 8 (Reuters) - Iovance Biotherapeutics Inc

* Says Timothy Morris appointed CFO

* Iovance Biotherapeutics appoints Timothy Morris as Chief Financial Officer

* Iovance Biotherapeutics Inc - ‍Morris was most recently Chief Financial Officer and head of business development for Acelrx Pharmaceuticals​ Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below